Association between mental health disorders, problem drug use, and regular prescription opioid use

Archives of Internal Medicine

Volumn 166, Issue 19, 2006, Pages 2087-2093

  Sullivan, Mark D ^a   Edlund, Mark J ^b   Zhang, Lily ^c   Unützer, Jürgen ^a   Wells, Kenneth B ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CANNABIS; OPIATE; SEDATIVE AGENT;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG MISUSE; DYSTHYMIA; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PANIC; PRESCRIPTION; PRIORITY JOURNAL; SOCIOECONOMICS;

ADULT; ANALGESICS, OPIOID; COMORBIDITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OPIOID-RELATED DISORDERS; PAIN; PRESCRIPTIONS, DRUG; PREVALENCE; QUESTIONNAIRES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 33750306183     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.19.2087     Document Type: Article

References (40)

1. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care [published correction appears in JAMA. 1998;280:1142]. JAMA. 1998;280:147-151.
2. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US. Pain. 2004;109:514-519.
3. Portenoy RK. Appropriate use of opioids for persistent non-cancer pain. Lancet. 2004;364:739-740.
4. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: flying blind? Pain. 2004;109:207-209.
5. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain. 2003;4:344-350.
6. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173-179.
7. Turk DC, Okifuji A. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain. 1997;13:330-336.
8. Sullivan MD, Edlund MJ, Steffick D, Unutzer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119:95-103.
9. Sturm R, Gresenz C, Sherbourne C, et al. The design of Healthcare for Communities. Inquiry. 1999;36:221-233.
10. Kemper P, Blumenthal D, Corrigan JM, et al. The design of the Community Tracking Study. Inquiry. 1996;33:195-206.
11. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1-10.
12. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
13. Aalto-Setala T, Haarasilta L, Marttunen M, et al. Major depression among young adults: CIDI-SF versus SCAN diagnoses. Psychol Med. 2002;32:1309-1314.
14. Composite International Diagnostic Interview (CIDI) Version 2.1. Geneva, Switzerland: World Health Organization; 1995.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
16. The Alcohol Use Disorders Identification Test (AUDIT): Guidelines for Use in Primary Health Care. Geneva, Switzerland: World Health Organization; 1992.
17. Sees KL, Clark HW. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage. 1993;8:257-264.
18. Miotto K, Compton P, Ling W, Conolly M. Diagnosing addictive disease in chronic pain patients. Psychosomatics. 1996;37:223-235.
19. Language Manual SUDAAN, Release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004.
20. Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology. Ann Intern Med. 2001;134:917-925.
21. Wasan AD, Davar G, Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain. 2005;117:450-461.
22. Harris KM, Edlund MJ. Self-medication of mental health problems: new evidence from a national survey. Health Serv Res. 2005;40:117-134.
23. Jackson S. Melancholia and Depression. New Haven, Conn: Yale University Press; 1986.
24. Narayanan S, Lam H, Christian L, et al. Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation. Neuroscience. 2004;124:241-246.
25. Bodkin JA, Zornberg GL, Lukas SE, Cole JO. Buprenorphine treatment of refractory depression. J Clin Psychopharmacol. 1995;15:49-57.
26. Koran LM, Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M. Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2005;66:353-359.
27. Mills KL, Teesson M, Ross J, Darke S, Shanahan M. The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder. Psychiatr Serv. 2005;56:940-945.
28. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. Am J Psychiatry. 1990;147:1002-1007.
29. Saper JR. Borderline personality, opioids, and naltrexone [letter]. Headache. 2000;40:765.
30. Sansone RA, Hawkins R. Fibromyalgia, borderline personality, and opioid prescription. Gen Hosp Psychiatry. 2004;26:415-416.
31. Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, Limberger MF, Bohme R, Schmahl CG. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder. J Clin Psychiatry. 1999;60:598-603.
32. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372-380.
33. Joint Commission on Accreditation of Healthcare Organizations, ed. Current understanding of assessment, management and treatments. Improving the Quality of Pain Management Through Measurement and Action. In: Reston, Va: National Pharmaceutical Council; 1991.
34. Recommendations for the Appropriate Use of Opioids for Persistent Non-Cancer Pain. 2004 Vol. London, England: Pain Society; 2004.
35. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain. 1997;13:6-8.
36. Drug Enforcement Administration. A joint statement from 21 health organizations and the Drug Enforcement Administration: promoting pain relief and preventing abuse of pain medications: a critical balancing act [guideline]. J Pain Symptom Manage. 2002;24:147.
37. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943-1953.
38. Chodosh J, Solomon DH, Roth CP, et al. The quality of medical care provided to vulnerable older patients with chronic pain. J Am Geriatr Soc. 2004;52:756-761.
39. Lin EH, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA. 2003;290:2428-2429.
40. Kennedy BP, Kawachi I, Glass R, Prothrow-Stith D. Income distribution, socioeconomic status, and self rated health in the United States: multilevel analysis. BMJ. 1998;317:917-921.